Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$92.92 - $109.35 $455,400 - $535,924
4,901 New
4,901 $473,000
Q3 2022

Nov 09, 2022

BUY
$90.51 - $207.38 $242,476 - $555,571
2,679 New
2,679 $244,000

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $80.9B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Blueprint Investment Partners LLC Portfolio

Follow Blueprint Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueprint Investment Partners LLC with notifications on news.